Cargando…
Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and In Vitro Validation
The lack of success in target-based screening approaches to the discovery of antibacterial agents has led to reemergence of phenotypic screening as a successful approach of identifying bioactive, antibacterial compounds. A challenge though with this route is then to identify the molecular target(s)...
Autores principales: | Mugumbate, Grace, Abrahams, Katherine A., Cox, Jonathan A. G., Papadatos, George, van Westen, Gerard, Lelièvre, Joël, Calus, Szymon T., Loman, Nicholas J., Ballell, Lluis, Barros, David, Overington, John P., Besra, Gurdyal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370846/ https://www.ncbi.nlm.nih.gov/pubmed/25799414 http://dx.doi.org/10.1371/journal.pone.0121492 |
Ejemplares similares
-
Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach
por: Mugumbate, Grace, et al.
Publicado: (2017) -
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface
por: Abrahams, Katherine A., et al.
Publicado: (2017) -
Development of a whole‐cell high‐throughput phenotypic screen to identify inhibitors of mycobacterial amino acid biosynthesis
por: Burke, Christopher, et al.
Publicado: (2019) -
Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020) -
Synthesis and recycling of the mycobacterial cell envelope
por: Abrahams, Katherine A, et al.
Publicado: (2021)